PAX1 Methylation Status in Cervical Scrapes as Novel Diagnostic Biomarker in CIN 2/3 and Invasive Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

PAX1 Methylation Status in Cervical Scrapes as Novel Diagnostic Biomarker in CIN 2/3 and Invasive Squamous Cell Carcinoma

Published:2022-10-01 Issue:6 Volume:72 Page:522-528
ISSN:0971-9202
Container-title:The Journal of Obstetrics and Gynecology of India
language:en
Short-container-title:J Obstet Gynecol India

Author:

Bhavya ^ORCID,Rajaram Shalini,Gupta Bindiya,Banerjee B. D.,Arora Vinod Kumar,Thakur Gaurav,Jain Sandhya

Funder

indian council of medical research

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology

Link

https://link.springer.com/content/pdf/10.1007/s13224-022-01680-5.pdf

Reference15 articles.

1. World Health Organization (WHO). Cervical Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2018. https://www.uicc.org/new-global-cancer-data-globocan-2018. Accessed on 25th jan. 2022.

2. Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol. 2006;208:152–64.

3. McCredie MR, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9:425–34.

4. Vink MA, Bogaards JA, van Kemenade FJ, de Melker HE, Meijer CJ, Berkhof J. Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data. Am J Epidemiol. 2013;178:1161–9.

5. Steenburgen RD, Snijders PJ, Heideman DA, Meijer CJ. Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer. 2014;14(6):395–405.